|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013089,
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0079083,
umls-concept:C0144576,
umls-concept:C0183683,
umls-concept:C0210630,
umls-concept:C0332283,
umls-concept:C0344211,
umls-concept:C0473169,
umls-concept:C0476089,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1521721,
umls-concept:C1522449
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-15
|
|
pubmed:abstractText |
To determine the toxicity, tolerability, and feasibility of delivering combination chemotherapy with subsequent radiation therapy to women with high-risk endometrial cancer and to evaluate the long-term bowel toxicity of this regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
198-203
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15589601-Adult,
pubmed-meshheading:15589601-Aged,
pubmed-meshheading:15589601-Aged, 80 and over,
pubmed-meshheading:15589601-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15589601-Brachytherapy,
pubmed-meshheading:15589601-Carboplatin,
pubmed-meshheading:15589601-Combined Modality Therapy,
pubmed-meshheading:15589601-Doxorubicin,
pubmed-meshheading:15589601-Drug Administration Schedule,
pubmed-meshheading:15589601-Endometrial Neoplasms,
pubmed-meshheading:15589601-Female,
pubmed-meshheading:15589601-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:15589601-Humans,
pubmed-meshheading:15589601-Middle Aged,
pubmed-meshheading:15589601-Neoplasm Staging,
pubmed-meshheading:15589601-Paclitaxel,
pubmed-meshheading:15589601-Pilot Projects,
pubmed-meshheading:15589601-Recombinant Proteins,
pubmed-meshheading:15589601-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
|
|
pubmed:affiliation |
Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. lduska@partners.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
